Image-derived Prediction of Response to Chemo-radiation in Glioblastoma

• Status: Terminated
• Trial end date: 2016-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study seeks to investigate if advanced image-analysis of diagnostic scans, can be used to predict how aggressive brain tumors (glioblastoma) respond to standard chemo- and radiation treatment.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rigshospitalet, Denmark
• Treatments: Temozolomide

Criteria

Inclusion Criteria:

• Histologically confirmed, primary supratentorial glioblastoma (WHO grade IV).

Exclusion Criteria:

• No informed consent can be obtained

• Inability to undergo MRI examination, due to metal implants, pacemaker etc.

• Not eligible for Stupp-regimen